CancerCare
Non-Profit & Charitable Organizations · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
76 Duke St, Barrow in Furness, Lancashir...Phone Number
+44 1229836926Website
www.cancercare.org.ukRevenue
$13.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About CancerCare
Macmillan Cancer Relief, doing business as Macmillan Cancer Support, provides practical, medical, emotional, and financial support to cancer care patients, friends, families, and communities. It operates cancer care units, as well as provides educational programs to train doctors, nurses, and students about cancer care. The company also provides emotional support through, phone, email, post, Web site, support groups, and trained professionals; financial support through grants; and information and support through mobile cancer information canters and campaigns. The company was founded in 1983 and is based in London and also has offices in Scotland, Ireland, Wales, and England.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CancerCare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CancerCare has recently received funding, and reach out quickly before it becomes old news!
CancerCare, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CancerCare has new funding data
Earning: See what the market has to say on CancerCare recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CancerCare
Product Launch: Get notified when CancerCare launches new products
Check out if CancerCare is spiking on competitors!
Click to see if CancerCare had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined CancerCare as Masked Content
Find 2 more new buyers
Compare Similar Companies to CancerCare
Compare insights from companies similar to CancerCare, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CancerCare
$13.9M
11-50
Private
-
1983
N/A
Company Profile Activity
Activity Insights
CancerCare is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
CancerCare is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about CancerCare.
CancerCare Tech Stack
Most Recent Scoops
Open Position
Open Position
Event
Person-Based
Gemma Peters, Chief Executive Officer, appeared on a podcast called "Third Sector Podcast" on 08/30/2024. Topics discussed include Macmillan's transformation, charity support, RNLI rescue.
Events, Podcast
Open Position
Open Position
CancerCare News & Media
Macmillan Cancer Support appoints Mr. President - Ethical Marketing News
Macmillan Cancer Support provides physical, emotional and financial support to people living with cancer and have appointed Mr. President. The appointment follows a competitive pitch that was part of a wider roster review by the cancer support charity, including the appointment of new agency partners across their full range of content requirements. Mr President published the following on their website here: We always aspire to use our creativity to do a bit of good inJanssen Seeks Expanded Use of IMBRUVICA®▼ (ibrutinib) in Two Indications in Europe
BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two Type II variation applications to the European Medicines Agency (EMA) seeking approval for the expanded use of IMBRUVICA® (ibrutinib). One application seeks to include use of ibrutinib in combination with obinutuzumab in previously untreated adults with chronic lymphocytic leukaemia (CLL) and to add long-term follow-up data from the existing label studies RESONATPfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has approved TRAZIMERA™,1 a biosimilar to Herceptin®* (trastuzumab), for the treatment of human epidermal growth factor (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.2 This approval follows the recommendation from the Committee for Medicinal Products for Human Use in May 2018.1 “TRAZIMERA has the potential to help many patien
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CancerCare
Sign Up For FreeTo access detailed company insights
Macmillan Cancer Relief, doing business as Macmillan Cancer Support, provides practical, medical, emotional, and financial support to cancer care patients, friends, families, and communities. It operates cancer care units, as well as provides educational programs to train doctors, nurses, and students about cancer care. The company also provides em... Read More
